Stockert Heater-Cooler Device Lawsuit

Stockert Heater-Cooler Device Lawsuit

New studies by the U.S. Food and Drug Administration have linked nontuberculous mycobacteria (NTM) infections to the heater-cooler devices that are used in cardiopulmonary bypass or open-heart surgeries. Although the symptoms of an NTM infection may take months or years to manifest, the infection can result in illness and ultimately lead to death.

The FDA issued a statement in October 2015 regarding the potential dangers of using these devices. Now, heater-cooler lawyers are aiding patients by investigating the link between the use of these devices and NTM infections as well as filing lawsuits for patients affected.

Heater-cooler devices serve the purpose of keeping the patient’s body temperature and blood cool during a heart operation by using water that is temperature-controlled. However, water may be contaminated, allowing the device to spread this harmful bacteria into the air. While a patient’s chest cavity is open during surgery, this infection can then easily enter their body. Many lawsuits have already been filed against the manufacturers of these devices as the result of unsafe products being sold that allow this bacteria to enter the body during an operation.

An estimated 250,000 heart bypass surgeries are performed annually in the United States. 60 percent of these heart bypass surgeries use the Sorin Stockert 3T. The CDC has stated that the chances of a patient contracting NTM during a procedure which uses this model are between 1 in 100 and 1 in 1,000. As a result, the CDC as well as the FDA have issued warnings about the risk of using this particular model.

NTM infections have killed several people and caused serious illness in many others. Investigations have found a link between these cases and the use of heater-cooler devices that use contaminated water. Two hospitals in Pennsylvania have informed patients that thousands of people who have received heart surgery on their premises may have been exposed to NTM as the result of the heater-cooler devices used.

Those who contract an NTM infection have a 50 percent chance of surviving. The symptoms are incredibly hard to treat and can take several years to manifest. Patients who have contracted NTM infections are filing lawsuits against the manufacturers of contaminated heater-cooler devices.

Should I File a Stockert Heater-Cooler Device Lawsuit?

Those who are infected with NTM may find it difficult to pay for medical bills. Sometimes surgery is required to eradicate tissue that has become infected. Treatment may lead to further complications. The FDA has found a strong link between NTM infections and the use of contaminated devices. After several studies, the FDA has discovered that heater-cooler devices use air filters that may not adequately capture NTM bacteria.

If you have contracted an NTM infection as the result of a contaminated heater-cooler device, contact our lawyers today.

Lawsuits over Xarelto Bleeding Problems

Lawsuits over Xarelto Bleeding Problems

Lawsuits over Xarelto Bleeding Problems

Pharmaceutical companies have the legal duty of making sure that their drugs do not put the health of patients at risk. When a pharmaceutical company fails to exercise reasonable duty of care, patients who suffer due to their negligence are eligible for compensation. The makers of Xarelto are no exception to this rule. Morgan & Morgan attorneys have filed a large number of lawsuits against Xarelto for the severe side effects of the blood thinner. Although bleeding is a normal reaction to anticoagulants, many patients report that the bleeding experienced after using Xarelto is more intense compared to conventional blood thinners. , Furthermore, unlike traditional coagulants using Vitamin K to stop the bleeding, Xarelto has no antidote to relieve the effects of the drug. Therefore, during an emergency, patients stand the risk of suffering from life-threatening gastrointestinal and internal hemorrhaging.

The Basis of the Lawsuits

The defendants in the Xarelto lawsuit based on the defective and dangerous effects of Xarelto are Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. Apart from the risks of the drug, the lawsuits allege that:

  • Xarelto was marketed as a superior anticoagulant though studies show that there is a higher rate of transfusion and bleeding among those who use Xarelto than those who use drugs from certain competitors
  • Despite the dangerous side effects of Xarelto, its manufacturers still market it as a reliable blood thinner
  • Consumers of Xarelto never received adequate warning about the risk of experiencing fatal bleeding after using the drug
  • Physicians and nurses did not receive adequate instruction on ways of stabilizing or dealing with a Xarelto patient who experiences severe bleeding after using the coagulant
  • Xarelto is associated with severe bleeding complications, intracranial hemorrhaging, excess blood loss, vitreous hemorrhage (eye bleeding), gastrointestinal bleeding, stomach bleeding, inability to stop dangerous clotting, and infections of wound due to inhibited clotting.

What Kind of Compensation are the Plaintiffs Seeking?

The main basis of these lawsuits is to receive compensation for damages associated with the Xarelto drug. The plaintiffs expect Bayer and Jansen to compensate them for medical bills incurred in the past and those likely to be incurred in the future. Other damages include pain and suffering, lost wages, funeral expenses in cases where patients have died from severe bleeding. In addition, the plaintiffs also want punitive damages to act as punishment for the defendants and as a warning against other pharmaceutical companies.

In case you or someone you love has experienced severe bleeding after using Xarelto, it is your right to seek legal redress. Contact us for a free case review and so we can help you review your options.